(2.3) After dilution in an intravenous infusion, refrigerate resulting solution unless used immediately
TB 500 is used in a variety of medical and performance-related treatments
It tends to look like reduced resilience across the board: slower recovery, less bandwidth, a body working harder to maintain the same ground
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
Explore your options on our Services page or Contact us to schedule a consultation
Researchers study NAD in work involving energy metabolism, mitochondrial function, and enzymatic pathways such as sirtuins and PARPs
